These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15080264)

  • 1. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome.
    Nissinen R; Paimela L; Julkunen H; Tienari PJ; Leirisalo-Repo M; Palosuo T; Vaarala O
    Scand J Rheumatol; 2003; 32(6):337-42. PubMed ID: 15080264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
    Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
    Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.
    Barakat S; Meyer O; Torterotot F; Youinou P; Briand JP; Kahn MF; Muller S
    Clin Exp Immunol; 1992 Jul; 89(1):38-45. PubMed ID: 1378364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
    Bodil Roth E; Theander E; Londos E; Sandberg-Wollheim M; Larsson A; Sjöberg K; Stenberg P
    Scand J Immunol; 2008 Jun; 67(6):626-31. PubMed ID: 18476880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
    Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
    Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies.
    Ghirardello A; Doria A; Zampieri S; Gerli R; Rapizzi E; Gambari PF
    Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
    Goules JD; Goules AV; Tzioufas AG
    Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
    Kakumanu P; Sobel ES; Narain S; Li Y; Akaogi J; Yamasaki Y; Segal MS; Hahn PC; Chan EK; Reeves WH; Satoh M
    J Rheumatol; 2009 Dec; 36(12):2682-90. PubMed ID: 19884269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis--new pathways to epitope spreading.
    Roth EB; Stenberg P; Book C; Sjöberg K
    Clin Exp Rheumatol; 2006; 24(1):12-8. PubMed ID: 16539813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis.
    Karsh J; Halbert SP; Anken M; Klima E; Steinberg AD
    Int Arch Allergy Appl Immunol; 1982; 68(1):60-9. PubMed ID: 6978853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
    Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
    Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum isoamylases in patients with autoimmune rheumatic diseases.
    Tsianos EB; Tzioufas AG; Kita MD; Tsolas O; Moutsopoulos HM
    Clin Exp Rheumatol; 1984; 2(3):235-8. PubMed ID: 6529876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.
    Girbal-Neuhauser E; Durieux JJ; Arnaud M; Dalbon P; Sebbag M; Vincent C; Simon M; Senshu T; Masson-Bessière C; Jolivet-Reynaud C; Jolivet M; Serre G
    J Immunol; 1999 Jan; 162(1):585-94. PubMed ID: 9886436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases.
    Dubucquoi S; Solau-Gervais E; Lefranc D; Marguerie L; Sibilia J; Goetz J; Dutoit V; Fauchais AL; Hachulla E; Flipo RM; Prin L
    Ann Rheum Dis; 2004 Apr; 63(4):415-9. PubMed ID: 15020336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.